Setting

Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity

Published: 28 Feb 2022 | Report Code: 10248400 | Pages: 180

Global CRISPR gene editing market will reach $16,329.8 million by 2031, growing by 26.4% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic. Highlighted with 87 tables and 86 figures, this 180-page report “Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global CRISPR gene editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global CRISPR gene editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Region. Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • CRISPR Products o Kits & Enzymes ? Vector-Based Cas9 ? DNA-Free Cas9 o Databases & Libraries o Design Tools o Antibodies o CRISPR Plasmid & Vector o Other Products • CRISPR Services o gRNA Design & Vector Construction o Cell Line Engineering o Microbial Gene Editing o DNA Synthesis o Other Services Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Biomedical Research & Therapy o Gene Therapy o Drug Discovery o Diagnostics o Other Biomedical Applications • Agriculture • Industrial Use • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharmaceutical Companies • Biotechnology Companies • Academic Institutions & Research Centers • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Switzerland, Russia, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Application, and End User, over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abcam, Inc. Agilent Technologies, Inc. Applied StemCell, Inc. Caribou Biosciences, Inc. Cellecta, Inc. CRISPR Therapeutics AG Editas Medicine, Inc. GeneCopoeia, Inc. GeneScript Biotech Corporation Horizon Discovery Group PLC Integrated DNA Technologies, Inc. Intellia Therapeutics Inc. Lonza Group Ltd. Merck KGaA New England Biolabs, Inc. Origene Technologies, Inc. Rockland Immunochemicals, Inc. Synthego Corporation System Biosciences LLC Takara Bio, Inc. Thermo Fisher Scientific, Inc. ToolGen, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction	9
1.1 Industry Definition and Research Scope	9
1.1.1 Industry Definition	9
1.1.2 Research Scope	11
1.2 Research Methodology	14
1.2.1 Overview of Market Research Methodology	14
1.2.2 Market Assumption	15
1.2.3 Secondary Data	15
1.2.4 Primary Data	15
1.2.5 Data Filtration and Model Design	16
1.2.6 Market Size/Share Estimation	17
1.2.7 Research Limitations	18
1.3 Executive Summary	19
2 Market Overview and Dynamics	21
2.1 Market Size and Forecast	21
2.1.1 Impact of COVID-19 on World Economy	24
2.1.2 Impact of COVID-19 on the Market	26
2.2 Major Growth Drivers	28
2.3 Market Restraints and Challenges	37
2.4 Emerging Opportunities and Market Trends	40
2.5 Porter’s Fiver Forces Analysis	44
3 Segmentation of Global Market by Offering	48
3.1 Market Overview by Offering	48
3.2 CRISPR Products	50
3.2.1 Kits & Enzymes	52
3.2.2 Databases & Libraries	53
3.2.3 Design Tools	54
3.2.4 Antibodies	55
3.2.5 CRISPR Plasmid & Vector	56
3.2.6 Other Products	57
3.3 CRISPR Services	58
3.3.1 gRNA Design & Vector Construction	60
3.3.2 Cell Line Engineering	61
3.3.3 Microbial Gene Editing	62
3.3.4 DNA Synthesis	63
3.3.5 Other Services	64
4 Segmentation of Global Market by Application	65
4.1 Market Overview by Application	65
4.2 Biomedical Research & Therapy	67
4.2.1 Gene Therapy	69
4.2.2 Drug Discovery	70
4.2.3 Diagnostics	71
4.2.4 Other Biomedical Applications	72
4.3 Agriculture	73
4.4 Industrial Use	74
4.5 Other Applications	75
5 Segmentation of Global Market by End User	76
5.1 Market Overview by End User	76
5.2 Pharmaceutical Companies	78
5.3 Biotechnology Companies	79
5.4 Academic Institutions & Research Centers	80
5.5 Other End Users	81
6 Segmentation of Global Market by Region	82
6.1 Geographic Market Overview 2021-2031	82
6.2 North America Market 2021-2031 by Country	86
6.2.1 Overview of North America Market	86
6.2.2 U.S.	90
6.2.3 Canada	93
6.2.4 Mexico	95
6.3 European Market 2021-2031 by Country	97
6.3.1 Overview of European Market	97
6.3.2 Germany	101
6.3.3 U.K.	103
6.3.4 France	105
6.3.5 Spain	107
6.3.6 Italy	109
6.3.7 Netherlands	111
6.3.8 Rest of European Market	113
6.4 Asia-Pacific Market 2021-2031 by Country	115
6.4.1 Overview of Asia-Pacific Market	115
6.4.2 Japan	119
6.4.3 China	122
6.4.4 Australia	124
6.4.5 India	126
6.4.6 South Korea	128
6.4.7 Rest of APAC Region	130
6.5 South America Market 2021-2031 by Country	132
6.5.1 Argentina	135
6.5.2 Brazil	137
6.5.3 Chile	139
6.5.4 Rest of South America Market	141
6.6 MEA Market 2021-2031 by Country	142
6.6.1 UAE	145
6.6.2 Saudi Arabia	147
6.6.3 South Africa	149
6.6.4 Other National Markets	151
7 Competitive Landscape	152
7.1 Overview of Key Vendors	152
7.2 New Product Launch, Partnership, Investment, and M&A	156
7.3 Company Profiles	157
Abcam, Inc.	157
Agilent Technologies, Inc.	159
Applied StemCell, Inc.	160
Caribou Biosciences, Inc.	161
Cellecta, Inc.	162
CRISPR Therapeutics AG	163
Editas Medicine, Inc.	164
GeneCopoeia, Inc.	165
GeneScript Biotech Corporation	166
Horizon Discovery Group PLC	167
Integrated DNA Technologies, Inc.	168
Intellia Therapeutics Inc.	169
Lonza Group Ltd.	170
Merck KGaA	171
New England Biolabs, Inc.	172
Origene Technologies, Inc.	173
Rockland Immunochemicals, Inc.	174
Synthego Corporation	175
System Biosciences LLC	176
Takara Bio, Inc.	177
Thermo Fisher Scientific, Inc.	178
ToolGen, Inc.	179
RELATED REPORTS	180
List Of Tables:


Table 1.  Snapshot of Global CRISPR Gene Editing Market in Balanced Perspective, 2021-2031	20
Table 2. World Economic Outlook, 2021-2031	25
Table 3. Developing Roadmap of CRISPR Technology	29
Table 4. Private and Public Companies Investment in CRISPR Technology	30
Table 5. Comparison of CRISPR with Other Gene Editing Technologies	33
Table 6. World Health Spending by Region, $ bn, 2013-2020	36
Table 7.  Main Product Trends and Market Opportunities in Global CRISPR Gene Editing Market	40
Table 8. Global CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	48
Table 9. Global CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn	51
Table 10. Global CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn	52
Table 11. Global CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn	59
Table 12. Global CRISPR Gene Editing Market by Application, 2021-2031, $ mn	65
Table 13. Global CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn	68
Table 14. Global CRISPR Gene Editing Market by End User, 2021-2031, $ mn	76
Table 15. Global CRISPR Gene Editing Market by Region, 2021-2031, $ mn	83
Table 16.  Leading National CRISPR Gene Editing Market, 2021 and 2031, $ mn	85
Table 17. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn	88
Table 18. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	92
Table 19. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn	92
Table 20. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn	92
Table 21. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	94
Table 22. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn	94
Table 23. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn	94
Table 24. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	96
Table 25. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn	96
Table 26. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn	96
Table 27. Europe CRISPR Gene Editing Market by Country, 2021-2031, $ mn	100
Table 28. Germany CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	102
Table 29. Germany CRISPR Gene Editing Market by Application, 2021-2031, $ mn	102
Table 30. Germany CRISPR Gene Editing Market by End User, 2021-2031, $ mn	102
Table 31. U.K. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	104
Table 32. U.K. CRISPR Gene Editing Market by Application, 2021-2031, $ mn	104
Table 33. U.K. CRISPR Gene Editing Market by End User, 2021-2031, $ mn	104
Table 34. France CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	106
Table 35. France CRISPR Gene Editing Market by Application, 2021-2031, $ mn	106
Table 36. France CRISPR Gene Editing Market by End User, 2021-2031, $ mn	106
Table 37. Spain CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	108
Table 38. Spain CRISPR Gene Editing Market by Application, 2021-2031, $ mn	108
Table 39. Spain CRISPR Gene Editing Market by End User, 2021-2031, $ mn	108
Table 40. Italy CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	110
Table 41. Italy CRISPR Gene Editing Market by Application, 2021-2031, $ mn	110
Table 42. Italy CRISPR Gene Editing Market by End User, 2021-2031, $ mn	110
Table 43. Netherlands CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	112
Table 44. Netherlands CRISPR Gene Editing Market by Application, 2021-2031, $ mn	112
Table 45. Netherlands CRISPR Gene Editing Market by End User, 2021-2031, $ mn	112
Table 46. CRISPR Gene Editing Market in Rest of Europe by Country, 2021-2031, $ mn	114
Table 47. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn	117
Table 48. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	121
Table 49. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn	121
Table 50. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn	121
Table 51. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	123
Table 52. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn	123
Table 53. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn	123
Table 54. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	125
Table 55. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn	125
Table 56. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn	125
Table 57. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	127
Table 58. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn	127
Table 59. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn	127
Table 60. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	129
Table 61. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn	129
Table 62. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn	129
Table 63. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn	131
Table 64. South America CRISPR Gene Editing Market by Country, 2021-2031, $ mn	134
Table 65. Argentina CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	136
Table 66. Argentina CRISPR Gene Editing Market by Application, 2021-2031, $ mn	136
Table 67. Argentina CRISPR Gene Editing Market by End User, 2021-2031, $ mn	136
Table 68. Brazil CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	138
Table 69. Brazil CRISPR Gene Editing Market by Application, 2021-2031, $ mn	138
Table 70. Brazil CRISPR Gene Editing Market by End User, 2021-2031, $ mn	138
Table 71. Chile CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	140
Table 72. Chile CRISPR Gene Editing Market by Application, 2021-2031, $ mn	140
Table 73. Chile CRISPR Gene Editing Market by End User, 2021-2031, $ mn	140
Table 74. MEA CRISPR Gene Editing Market by Country, 2021-2031, $ mn	144
Table 75. UAE CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	146
Table 76. UAE CRISPR Gene Editing Market by Application, 2021-2031, $ mn	146
Table 77. UAE CRISPR Gene Editing Market by End User, 2021-2031, $ mn	146
Table 78. Saudi Arabia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	148
Table 79. Saudi Arabia CRISPR Gene Editing Market by Application, 2021-2031, $ mn	148
Table 80. Saudi Arabia CRISPR Gene Editing Market by End User, 2021-2031, $ mn	148
Table 81. South Africa CRISPR Gene Editing Market by Offering, 2021-2031, $ mn	150
Table 82. South Africa CRISPR Gene Editing Market by Application, 2021-2031, $ mn	150
Table 83. South Africa CRISPR Gene Editing Market by End User, 2021-2031, $ mn	150
Table 84. Breakdown of World Market by Key Vendor, 2021, %	154
Table 85. Abcam, Inc.: Company Snapshot	157
Table 86. Abcam, Inc.: Business Segmentation	158
Table 87. Abcam, Inc.: Product Portfolio	158
List Of Figures:


Figure 1. Research Method Flow Chart	14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	19
Figure 4. Global CRISPR Gene Editing Market, 2021-2031, $ mn	21
Figure 5. Categories of CRISPR-Cas Systems	22
Figure 6. Impact of COVID-19 on Business	26
Figure 7. Primary Drivers and Impact Factors of Global CRISPR Gene Editing Market	28
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	34
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	35
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	35
Figure 11. Primary Restraints and Impact Factors of Global CRISPR Gene Editing Market	37
Figure 12. Investment Opportunity Analysis	41
Figure 13. Porter’s Fiver Forces Analysis of Global CRISPR Gene Editing Market	44
Figure 14. Breakdown of Global CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue	49
Figure 15. Global Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	49
Figure 16. Global CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn	50
Figure 17. Global CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn	52
Figure 18. Global CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn	53
Figure 19. Global CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn	54
Figure 20. Global CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn	55
Figure 21. Global CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn	56
Figure 22. Global CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn	57
Figure 23. Global CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn	58
Figure 24. Global CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn	60
Figure 25. Global CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn	61
Figure 26. Global CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn	62
Figure 27. Global CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn	63
Figure 28. Global CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn	64
Figure 29. Breakdown of Global CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue	66
Figure 30. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	66
Figure 31. Global CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn	67
Figure 32. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn	69
Figure 33. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn	70
Figure 34. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn	71
Figure 35. Global CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn	72
Figure 36. Global CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn	73
Figure 37. Global CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn	74
Figure 38. Global CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn	75
Figure 39. Breakdown of Global CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue	77
Figure 40. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	77
Figure 41. Global CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn	78
Figure 42. Global CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn	79
Figure 43. Global CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn	80
Figure 44. Global CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn	81
Figure 45.  Global Market Snapshot by Region	82
Figure 46.  Geographic Spread of Worldwide CRISPR Gene Editing Market, 2021-2031, % of Sales Revenue	83
Figure 47. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)	84
Figure 48.  North American CRISPR Gene Editing Market, 2021-2031, $ mn	87
Figure 49. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	88
Figure 50. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	89
Figure 51. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn	91
Figure 52. Canada CRISPR Gene Editing Market, 2021-2031, $ mn	93
Figure 53.  CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn	95
Figure 54.  European CRISPR Gene Editing Market, 2021-2031, $ mn	98
Figure 55. Breakdown of European CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	99
Figure 56. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	100
Figure 57.  CRISPR Gene Editing Market in Germany, 2021-2031, $ mn	101
Figure 58.  CRISPR Gene Editing Market in U.K., 2021-2031, $ mn	103
Figure 59.  CRISPR Gene Editing Market in France, 2021-2031, $ mn	105
Figure 60.  CRISPR Gene Editing Market in Spain, 2021-2031, $ mn	107
Figure 61.  CRISPR Gene Editing Market in Italy, 2021-2031, $ mn	109
Figure 62.  CRISPR Gene Editing Market in Netherlands, 2021-2031, $ mn	111
Figure 63.  CRISPR Gene Editing Market in Rest of Europe, 2021-2031, $ mn	113
Figure 64. Asia-Pacific CRISPR Gene Editing Market, 2021-2031, $ mn	116
Figure 65. Breakdown of APAC CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	116
Figure 66. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	118
Figure 67.  CRISPR Gene Editing Market in Japan, 2021-2031, $ mn	120
Figure 68.  CRISPR Gene Editing Market in China, 2021-2031, $ mn	122
Figure 69.  CRISPR Gene Editing Market in Australia, 2021-2031, $ mn	124
Figure 70.  CRISPR Gene Editing Market in India, 2021-2031, $ mn	126
Figure 71.  CRISPR Gene Editing Market in South Korea, 2021-2031, $ mn	128
Figure 72.  CRISPR Gene Editing Market in Rest of APAC, 2021-2031, $ mn	130
Figure 73. South America CRISPR Gene Editing Market, 2021-2031, $ mn	133
Figure 74. Breakdown of South America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	133
Figure 75. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	134
Figure 76.  CRISPR Gene Editing Market in Argentina, 2021-2031, $ mn	135
Figure 77.  CRISPR Gene Editing Market in Brazil, 2021-2031, $ mn	137
Figure 78.  CRISPR Gene Editing Market in Chile, 2021-2031, $ mn	139
Figure 79.  CRISPR Gene Editing Market in Rest of South America, 2021-2031, $ mn	141
Figure 80. CRISPR Gene Editing Market in Middle East and Africa (MEA), 2021-2031, $ mn	143
Figure 81. Breakdown of MEA CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue	143
Figure 82. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	144
Figure 83.  CRISPR Gene Editing Market in UAE, 2021-2031, $ mn	145
Figure 84.  CRISPR Gene Editing Market in Saudi Arabia, 2021-2031, $ mn	147
Figure 85.  CRISPR Gene Editing Market in South Africa, 2021-2031, $ mn	149
Figure 86. Growth Stage of Global CRISPR Gene Editing Industry over the Forecast Period	152
Selected Key Players: 
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)